Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009 INTRODUCTION Multiple sclerosis (MS) is a disease of complex aetiology, including genetic and environmental elements. 1 A key part of unravelling MS aetiology comes from studies investigating its occurrence and distribution within communities and globally. Timetrend studies, where serial cross-sectional studies are analysed over time, describe the evolution of MS in populations. These studies allow hypothesis generation about MS aetiology and provide invaluable data for the resource allocation and care for those affected.
Australia has played an important role in MS research, with a number of epidemiological studies undertaken. 2e6 Two landmark studies provided important data concerning the geographic and temporal distribution of MS: the first, by McCall and colleagues 2 in 1968, and the second, by Hammond and colleagues 3 in 1988, investigated the epidemiology of MS in the cities of Newcastle (NSW), Perth (WA) and Hobart (TAS) . Both studies demonstrated a significant latitudinal gradient characterised by higher prevalence and incidence rates with increasing latitude: the MS prevalence and incidence in Hobart (42.88S) were nearly double that of Newcastle (32.98S) and Perth (31.68S). Indeed, other work has demonstrated that the MS prevalence in Hobart is over six times that of northern Queensland. 4 This latitudinal gradient has also been observed in New Zealand, 7 Japan, 8 France 9 and the USA, 10 and has been borne out in meta-analyses of prevalence 11 and incidence. 12 Additionally, both prevalence and incidence increased between the McCall 2 and Hammond 3 studies in each of the three study sites. This temporal gradient continued in 1996, when Barnett and colleagues 10 undertook a follow-up study in Newcastle in 1997.
While Newcastle has been the focus of continued follow-up in the three-city studies, there have been no follow-up studies in Hobart. We 
METHODS

Study region and population
The Greater Hobart Statistical Division, hereafter referred to as Hobart, lies astride the lower Derwent River in the island state of Tasmania, at latitude 42.88S. Since 1961, the statistical division has grown from 272 km 2 to its present size of 1360 km 2 (figure 1). Despite the 400% increase in area, the population increased only 86.9% between 1961 and 2009, from 113 932 to 212 959. The population structure changed appreciably, however, from a 'youth-bulge' distribution in 1961 and 1981, to an 'apple-core' distribution in 2001 and 2009, reflecting an older age structure (figure 2). 15 were used, including probable, early-probable and possible cases. In the Hammond study, the Rose 16 criteria were used, including definite, probable and possible cases.
Context and case ascertainment
Epidemiological measures Divisions of epidemiological measures
There are two major divisions of prevalence, incidence and mortality used in this analysis: by sex and by birthplace. Sex is divided into male and female, with the value for all persons referred to as the total. Birthplace is divided into Australianborn, which includes those persons born in any of the states of Australia, and overseas-born, which includes those persons born outside the territorial borders of Australia; the value for all persons, regardless of birthplace, is referred to as the aggregate.
Calculation of epidemiological measures
Crude point prevalence was calculated by dividing the number of cases in the study region on prevalence day by the population on prevalence day, expressed as a proportion per 100 000.
Crude mean annual incidence rate (incidence) was calculated by dividing the number of new cases with symptom-onset and living in the study region during the observation period by an estimate of the person-years of observation on the population at risk. For comparability across studies, total person-years were calculated as the midpoint population multiplied by the length in years of the observation period. Incidence was expressed as a rate per 100 000 person-years. The crude mean annual mortality was calculated in an analogous manner.
To calculate prevalence by birthplace 
Calculation of distributions by birthplace
For the McCall and Hammond studies, prevalence and incidence were not reported with stratification by birthplace and by sex. Using the distribution by sex and by birthplace provided in each publication, we were able to calculate the distribution by birthplace and by sex of prevalence for each study and incidence for the Hammond study.
Age standardisation
All age standardisation was done using the direct method. 17 No single population could be used for age standardisation in this analysis, given the variability in the presentation of agespecific rates in the McCall and Hammond publications. Incidence and mortality were age-standardised to the 1954 Hobart population because this population was used to calculate summary measures in the McCall study, which did not provide age-specific rates. The mortality data reported for 1981 are not age-standardised and are not strictly comparabledto assess possible confounding bias, we performed a sensitivity analysis between 1971e1981 and 2001e2009, standardising the latter to the 1976 Hobart population, the population used to calculate mortality during 1971e1981.
Incidence by birthplace was age-standardised to the 1981 Australian population. This population was used to standardise incidence by birthplace in the Hammond study. The McCall study did not report incidence by birthplace.
Sex-specific prevalence and incidence by birthplace for 1971e1981 are not age-standardised, as these values were not provided as age-specific rates. Sex-specific prevalence by birthplace for 2001 and 2009, and sex-specific incidence by birthplace for 2001e2009 were age-standardised to the 1981 Hobart population to allow comparability with the crude sex-specific values from the Hammond study.
Population data
All population data were obtained from the relevant quincennial Census or annual population estimates published by Australian Bureau of Statistics (ABS). 18 All immigration data were obtained from the ABS 18 or the Australian Bureau of Immigration and Multicultural affairs. 19 
Statistical analysis
Poisson regression 17 was used to assess the significance of changes over time in all epidemiological measuresdbinary (0/1) terms were included as covariates for each 10-year age-group and for sex, while study year was included as a continuous covariate, with population entered as an offset. In assessing the change over time, the coefficient of the year term was used; in assessing the change in the sex ratio, the coefficient of a (sex3year) product term was assessed.
To assess the significance of differences in characteristics of the 2001 and 2009 case samples, a two-sample t test and c 2 test were used.
All statistical analyses were carried out using STATA/SE for Windows software (Version 10.1; StataCorp LP).
RESULTS
and 2009 studies
In 2001, 326 people were identified as potential MS cases. Of these, 63 were excluded for not having a clinically definite diagnosis on prevalence day, and 47 were not living in the study region, leaving 229 eligible cases. The majority (80.8%) of these were recruited from other MS studies conducted by the Menzies Research Institute, with the remainder recruited by neurologist referral (19.2%).
In 2009, 371 people were identified as potential MS cases. Of these, 43 were excluded for not having a clinically definite diagnosis on prevalence day, and 41 were not living in the study region, leaving 265 eligible cases. The majority of these were prevalent cases in the 2001 study (63.4%), with the remainder recruited by referral from a neurologist (10.2%), the local MS Society (23.0%) or other studies (3.4%). Table 1 Prevalence: 1961 to 2009 Table 2 shows the age-and sex-specific prevalence for each of the four studies. Figure 3 depicts the age-standardised prevalence values by sex over the four studies. There was a significant increase in the total (p<0.001), male (p¼0.001) and female Table 3 shows the prevalence by sex and birthplace for each of the four studies; figure 4 Figure 5 shows the change in prevalence for males and females by birthplace and for the aggregate. The patterns of change for males and females are similar. The changes in the aggregate reflect those of the Australian-born, due to the much larger numbers of cases contributed by this source. Of note is the difference in trend by sex among the Australian-born between 2001 and 2009, with males deceasing while females continue to increase, though neither of these changes reach statistical significance.
Prevalence by birthplace: 1961 to 2009
Incidence: 1951e1961 to 2001e2009
The total aggregate incidence increased significantly between 1951e1961 and 2001e2009 (p¼0.04), from 2.2 in 1951e1961, to 3.6 in 1971e1981 and 3.7 in 2001e2009. However this change was confined to the first two periods (p¼0.04), with no significant change thereafter (p¼0.91). Figure 6 shows the change in incidence by sex and birthplace between 1971e1981 and 2001e2009. While total and aggregate incidence remained unchanged between 1971e1981 and 2001e2009, the incidence for overseas-born groups decreased significantly (p<0.001 for males and total; p¼0.006 for females). Among Australian-born, only female incidence increased significantly (p¼0.017), while males and the total were statistically unchanged.
Prevalence and incidence sex ratios: 1951 to 2009
As shown in figure 7 , there was no change in the aggregate prevalence sex ratio (PSR) between 1961 and 2009 (p¼0.58), or in the Australian-born PSR (p¼0.50) or overseas-born PSR (p¼0.86) (figure 7).
The incidence sex ratio (ISR) increased between the 1971e1981 and 2001e2009 study periods, from 1.1 (95% CI 0.8 to 1.6) to 2.1 (95% CI 1.4 to 3.0), but this was not significant (p¼0.18). The ISR among the Australian-born increased almost significantly (p¼0.06) from 1.2 (95% CI 0.9 to 1.6) to 1.9 (95% CI 1.5 to 2.5). Among the overseas-born, the ISR was 1.1 (95% CI 0.6 to 2.1) in 1971e1981; the 2001e2009 ISR was undeterminable as the male overseas-born incidence in 2001e2009 was zero.
Mortality and longevity
The mortality decreased from 2.4/100 000 in 1951e1959 to 
DISCUSSION
We have undertaken a two-stage study of MS frequency in Hobart between 2001 and 2009 and, in combination with previously published studies, have conducted a time-trend analysis of MS epidemiology in Greater Hobart over the 58-year period from 1951 to 2009. This is the longest such study of MS frequency in the Southern hemisphere and comparable in length with the longest study durations in the Northern hemisphere. 20 21 We found high rates of MS, with crude prevalences of 116.1/100 000 in 2001 and 125.2/100 000 in 2009, a marked increase from the 1961 prevalence of 32.5/100 000. This persists after age standardisation, now a threefold increase to a 2009 prevalence 99.6/100 000, increasing by 14/100 000 every 10 years. The significant effect of age-standardisation reflects the ageing of the Hobart population over this interval and accounts for a portion of the increase in prevalence.
Over 2001e2009, we observed a crude incidence of 3.7/ 100 000, nearly double the 1951e1961 incidence of 2.2/100 000; this increase persists on age standardisation. Importantly, we observed significant differences by birthplace in the trends in both prevalence and incidence. Australian-born prevalence and incidence showed a steady increase over time, while overseasborn prevalence and incidence increased markedly up to 1981, whereupon prevalence and incidence fell precipitously. The 2001e2009 age-standardised mortality was 1.0/100 000, less than half that of the 1951e1961 period (2.4/100 000). This reduced mortality, along with a significant increase in the mean age of the prevalent cohort, from 41.0 to 46.4 years, manifest in increased case longevity. *For the 1961 study, the age-specific counts and prevalence rate were provided only for the 10e29 age group, rather than 10e19 and 20e29 as in the subsequent studies.
Epidemiology by place
Hobart (42.88S) had the highest reported prevalence and incidence of MS in Australia at all time points. In the current study, the 2001 Hobart prevalence (116.1/100 000) was nearly double that of Newcastle (32.98S) in 1996 (59.1/100 000). 6 The incidence for the 2001e2009 period (3.7/100 000) was 1.5 times higher than the 1986e1996 Newcastle incidence (2.4/100 000) 6 
Epidemiology over time
We observed a threefold increase in the age-standardised prevalence from 1961 to 2009. Such increases in prevalence over time are common in serial prevalence studies. 2 3 6 7 23 Poskanzer 24 suggests that an increase in prevalence in a serially measured population may reflect increased incidence, differential emigration between cases and non-cases, changes in population structure, increased duration of disease and/or changes in case ascertainment. In our study area, between 1951e1961 and 2001e2009, the age-standardised incidence increased from 2.2/ 100 000 to 3.7/100 000, contributing to increased prevalence (figure 6). We have no information regarding differential migration between cases and non-cases, but we also have no reason to assume such a difference. Figure 2 demonstrates there has been a considerable change in the Hobart population structure, but this has been addressed by age standardisation. Along with an ageing of the population, however, there has been an increase in the mean age of the prevalent MS cohort which, acting in concert with the decreased mortality, manifests in a significantly increased duration of disease in Hobart, accounting for a further component of the prevalence increase. Specialist neurological care has been provided for MS cases in Hobart throughout the study period, and it is unlikely that changes in prevalence and incidence can be traced to differences in this part of case ascertainment. However, changes in the diagnostic criteria used, from the Allison and Millar criteria used by McCall and colleagues and the Rose criteria used by Hammond and colleagues, to the 2001 and 2005 McDonald criteria used in our prevalence studies, do impact prevalence estimates. In one aspect, the increase in prevalence may be partially due to the increased sensitivity of diagnostic criteria over time, allowing for the detection of less 'typical' cases, particularly progressive courses which were not explicitly allowed for under the Allison & Millar criteria. Use by modern criteria of paraclinical evidence such as MRI allows for the inclusion of such cases. At the same time, however, the lower specificity of the earlier criteria, reliant solely on clinical evidence and history, allowed the inclusion of similar but non-MS neurological conditions as 'possible' MS, a group which was included in the McCall and Hammond calculations of prevalence and incidence. Studies comparing prevalence using these criteria with the 1984 Poser criteria 25 showed a higher prevalence with the Allison and Millar criteria (8.7% to 18.4%) 26 27 and the Rose criteria (1.6% to 11.9%). 5 28 Of note, studies comparing the Poser 25 and 2001 McDonald 13 criteria (the criteria used in our 2001 study), found little (0.7%) or no difference in their diagnostic allocation 29 30 ; a study 31 
Effects of migration
There were significant differences in the changes in prevalence and incidence over time by birthplace. Among Australian-born, there was a steady increase in prevalence and incidence over all study points; among the overseas-born, there were significant increases in the prevalence and incidence up to 1981, whereupon there were significant declines, prevalence falling precipitously after 1981 and incidence being reduced to near zero by 2001e2009. These findings may be explained by the Australian assisted-migration scheme of 1945e1981. Australia was founded and largely populated by immigrants from the UK. 32 Following the Second World War, Australia sought to drastically increase Figure 3 Prevalence by sex and for total for Greater Hobart: 1961e2009, age-standardised to the 1961 Greater Hobart population. Significance of change from previous study assessed by Poisson regression. *p<0.05; **p<0.01. the population, and the Australian government began providing assisted migration, from 1945 until 1981. 32 Over this period, 3.8 million migrants came to Australia, the largest fraction (38.8%) coming from the UK, 18 32 and the majority (52.8%) of them male. 18 32 After the termination of assisted-migration in 1981, the demographics of immigrants shifted, changing from mostly coming from high-prevalence 11 12 and higherlatitude (average: 42.928) nations in Europe and North America (82.2%) to mostly from low-prevalence 11 12 and low-latitude (average: 28.428) nations (57.6%), particularly in Asia/Oceania (32.8%). 32 The effects of assisted-migration are now fading, as evidenced by the decreasing prevalence among the overseas-born in 2001 and 2009 (figures 4, 5) and the sharply decreased overseas-born incidence in 2001e2009 (figure 6). However, this mass influx of genetically susceptible immigrants up to 1981, and its abrupt cessation thereafter, had significant effects on MS epidemiology in Hobart over 1951e2009. Therefore, MS epidemiology in Hobart over 1951e2009 is actually a tale of two populations. Only upon extricating these two populations from one another can sense be made of the whole and assumptions about future trends madedsuch predictions of future trend are important in planning hospital and health services.
Sex ratios over time
We found no significant change in the age-standardised PSR over 1961e2009, in line with other studies. 2 6 7 23 33e36 Only in one location has a significant change in the age-standardised PSR been found, in Ferrara province, Italy between 1978 37 and 2004, 22 increasing from 1.1 to 2.4 (p<0.05). Among the Australian-born, we observed a near-significant (p¼0.06) increase in the ISR between 1971e1981 and 2001e2009, increasing from 1.2 to 1.9. In the aggregate, we found a trend to increased ISR, nearly doubling from 1.1 to 2.1. While this trend did not reach significance, this likely reflects the small number of incident cases in both periods, with insufficient power resulting in a lack of statistical significance. Certainly elsewhere, significant changes in the ISR have been observed 38 : in Canada, 39 the ISR increased significantly over 50 years (1.014 per year over 1931e1980). In Oslo, 20 the ISR increased significantly, from 1.48 to 2.30 over 1910e1980. While these data do show a smaller increase in the ISR than that observed by others, 6 20 39 the trend to increased ISR is in keeping with the literature. 38 It may be that this smaller magnitude of the change in ISR is a reflection of a differential effect of latitude on MS risk by sex. Such a result is borne out in our recent work, 40 where the ISR of first demyelinating events varied inversely with latitude within Australia, with a 2.7-fold higher sex ratio in Brisbane (27.38S) than Hobart (42.88S).
Strengths and limitations
A key strength of this study is the long time-span that was studied. The medical infrastructure and specialist neurological care available throughout the period makes it possible to largely discount the possibility of differential case ascertainment. Also, the relatively high number of cases available for study in a stable and geographically confined, genetically susceptible population makes this an ideal location for long-term study of MS epidemiology.
There were some limitations in our study. We were restricted to the data presented in the McCall and Hammond publications, thus requiring diverse age-standardisations as described in the Methods. However, when sensitivity analyses were undertaken these assumptions did not significantly alter any outcomes.
CONCLUSION
Our results show a continuing increase in the prevalence and incidence of MS in Greater Hobart, particularly when the analysis is restricted to Australian-born. In our study area, between 1951e1961 and 2001e2009 the age-standardised incidence increased from 2.2/100 000 to 3.7/100 000. As well as this increase in incidence, increased longevity and a decreased mortality have significantly contributed to the increasing prevalence and have manifested in a significantly older cohort. While these data show a trend to increased ISR, this increase is much smaller and less significant that that observed elsewhere, suggesting a differential relationship between prevalence and latitude by sex. Figure 7 Prevalence sex ratio (female/male) for prevalence by birthplace and for the aggregate. Significance assessed by Poisson regression.
